Sun Pharma plans in-licensing, buyouts to expand speciality business

Speciality drugs refer to high cost, high complexity medicines, including biologicals, for the treatment of complex or rare conditions. They have limited competition or are protected by patents.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/y5zYJTi
via IFTTT